Search Results
Mar 20, 2026, 10:16 ET Linear Actuators Market Set for USD 87 Billion Milestone as Electrification Replaces Legacy Hydraulics; New Analysis by Maximize Market Research Highlights 7.5% CAGR through 2032
shift is the City of Toronto's recent upgrade of its municipal water treatment infrastructure, where hydraulic gate valves were replaced with IO-Link integrated electric actuators to enable real-time flow diagnostics. This move toward 'Smart Motion' within the utility-scale linear actuators
More news about: Maximize Market Research Pvt. Ltd.
Mar 20, 2026, 09:03 ET Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations
strengthen its platform-based innovation capabilities, establishing a multi-dimensional technology ecosystem. This includes a next-generation immuno-oncology (IO) platform, the proprietary Hanjugator™ ADC platform, a tri-specific T-cell engager (TCE) platform, and HAI Club—an AI-driven, integrated platform for
More news about: Henlius
Mar 20, 2026, 05:06 ET Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
ATG-125 (B7-H3 × PD-L1 bispecific ADC): ATG-125 is an "IO + ADC" dual-function molecule targeting B7-H3 and PD-L1, integrating the direct cytotoxic activity of an ADC with the durable immune activation of IO therapies. By simultaneously blocking B7-H3- and PD-L1-mediated immunosuppressive
More news about: Antengene Corporation Limited
Mar 20, 2026, 02:06 ET Arcfra AECP 6.3 Breaks the 11M IOPS Barrier, Delivering Tier-1 All-Flash Performance and RPO=0 Resilience for Enterprise Cloud
latency in 4K Random Read.These breakthroughs are driven by Intel® Data Streaming Accelerator (DSA) integration, a modernized IO_uring stack, and 8-stripe virtual volumes that maximize storage parallelism without manual tuning.Zero-Risk Business Continuity for Mission-CriticalsTo
More news about: Arcfra
Mar 19, 2026, 09:44 ET Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
(NASDAQ: OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidiary, Woori IO Co., Ltd. ("Woori IO"), has entered into a mutual non-disclosure agreement ("NDA") with Sinopharm Group Beijing Huahong ("Sinopharm"), the Beijing-based unit of
More news about: OSR Holdings
Mar 18, 2026, 09:40 ET Sands China Presents "A Century of Iec Long Firecracker Factory in Radiance - An Exhibition on the Resonant History and Aesthetic Memory of Macao Firecrackers"
numerous solo exhibitions in Macao, Hong Kong, the Chinese mainland, and Europe.In 2019, he formed the "Yiima" art group with local artist Chan Hin Io. In the same year, they held their first major exhibition at the Berardo Collection Museum in Lisbon; in 2022, they represented the Macao SAR at the 59th
More news about: Sands China Ltd.
Mar 17, 2026, 20:30 ET Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs
Convention Center, California, the United States. The presentations will feature ATG-125 (B7-H3 x PD-L1 bispecific antibody-drug conjugate [ADC]), an IO + ADC dual-function molecule being developed for the treatment of solid tumors, as well as two investigational T cell engagers (TCEs) developed using
More news about: Antengene Corporation Limited
Mar 13, 2026, 04:00 ET Amber Premium Announces First 2026 English-Language Digital Asset Webinar, Building on Record Audience Growth
Ambergroup_io
More news about: Amber Group; Amber Premium
Mar 12, 2026, 11:20 ET Embedded Insurance Market Outlook: 30%+ CAGR Forecast Through 2031; Online and API-First Placements Held 76.38% Share in 2025, Reports Mordor Intelligence
InsuranceAckoRootAllianz PartnersAllstate Protection PlansMulberriFletchBubbleReinBsurancePenn‑IoFetchaQuoteGet in-depth industry insights on the embedded insurance market research report:
More news about: Mordor Intelligence Private Limited
Mar 12, 2026, 09:01 ET d-Matrix and Gimlet Labs to Deliver 10x Speed Ups, Massive Power Efficiency for Frontier AI Workloads
pioneering accelerated computing for AI inference, breaking through the limits of latency, cost and energy. Its Corsair compute accelerators, JetStream IO accelerators, and Aviator software deliver fast, sustainable AI inference at data center scale. Learn more at
More news about: d-Matrix
Mar 11, 2026, 07:30 ET NextVision Reports Record Results Exceeding Board Targets for the Fifth Consecutive Year
Webinar:https://gk-biz.zoom.us/webinar/register/WN_OIes4GRvQ7io5JQhkrFwgAFor the English Webinar:
More news about: NextVision
Mar 10, 2026, 17:31 ET CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
Mesoblast, Genmab, Novartis, Teva Pharmaceutical Industries, Karyopharm Therapeutics, AB Science, Genentech, Eli Lilly and Company, Rafael Pharmaceuticals, IO Biotech, ImmuneOnco Biopharma, Chongqing Precision Biotech, Rhizen Pharmaceuticals, Nanjing Legend Biotech, Tokalas, Arvinas, MorphoSys AG, Shanghai
More news about: DelveInsight Business Research, LLP
Mar 10, 2026, 11:54 ET Import.io Launches Aperture
https://mma.prnewswire.com/media/2925241/Import_io_Logo.jpgPhoto -
More news about: Import.io
Mar 09, 2026, 00:30 ET Movate and Kahuna Labs Partner to Underwrite the Future of Technical Support with AI-Driven Outcomes
telecom, media, retail and e-commerce, CPG, healthcare, financial services, automotive and manufacturing, powered by its W(AI)VE™ framework and the Mova iO suite.To know more, visit: www.movate.com. Follow Movate on
More news about: Movate
Mar 05, 2026, 12:05 ET CIQ Introduces the CIQ Linux Kernel, Built to Unlock the Full Performance of Modern AI Hardware in Enterprise Production
the LT branches is included in CLK. When a CVE is fixed upstream, it is fixed in CLK.Emerging technology support: Features such as io_uring, eBPF, memory tiering (CXL/HBM) and confidential computing extensions (TDX, SEV-SNP) reach CLK users in production-ready form as they are stabilized
More news about: CIQ
Mar 05, 2026, 09:00 ET Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
https://www.pharmiweb.com/press-release/2026-02-09/immuno-oncology-io-market-size-share-growth-analysis-and-forecast-to-2030Logo -
More news about: Equity Insider
Mar 04, 2026, 21:26 ET Cadonilimab Achieves 100% 24-Month OS in Complete Responders in R/M Cervical Cancer Based on Long-Term Phase II Results
registrational/Phase III studies across major first-line tumor indications, various cold tumors, and IO-resistant settings, including a global Phase III trial in first-line gastric cancer and a global registrational trial in IO-resistant hepatocellular carcinoma.While advancing cadonilimab's global clinical
More news about: Akeso, Inc.
Mar 04, 2026, 08:52 ET Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
and a Phase II registrational trial for the second-line treatment of liver cancer in patients who exhibit resistance to immune checkpoint inhibitors (IO).INO-5412 is composed of INO-5401 and T cell immune activator INO-9012. When combined with a checkpoint blockade, targeted DNA immunotherapy has
More news about: Akeso, Inc.
Mar 04, 2026, 08:05 ET INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
and a Phase 2 registrational trial for the second-line treatment of liver cancer in patients who exhibit resistance to immune checkpoint inhibitors (IO).Dr. David Reardon, Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute and a professor at Harvard Medical School said,
More news about: INOVIO Pharmaceuticals, Inc.
Feb 23, 2026, 17:00 ET Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
dedicated to expanding our impact as part of our R&D strategy. Our deep expertise in this disease area, combined with a growing immuno-oncology (IO) pipeline of biologics, including T-cell engagers, uniquely positions us to help advance VIR-5500, a potentially best-in-class T-cell engager for prostate
More news about: Astellas Pharma Inc.
Feb 23, 2026, 11:15 ET MiRus® Receives FDA 510(k) Clearance for IO™ Expandable Wedge Osteotomy System
multimedia:https://www.prnewswire.com/news-releases/mirus-receives-fda-510k-clearance-for-io-expandable-wedge-osteotomy-system-302694722.htmlSOURCE
More news about: MiRus
Feb 19, 2026, 16:05 ET Farmer Mac Reports 2025 Results
1,152,988IO-FMGS(2)
More news about: Farmer Mac
Feb 18, 2026, 08:05 ET NatGold Digital Completes Successful FYEO Security Code Review and Publishes Results
https://github.com/fyio-io/NatGoldScope and Objectives of the EngagementThe review was initiated by NatGold with the principal objectives to:
More news about: NatGold Digital Ltd.
Feb 17, 2026, 11:35 ET Form.io Powers SpecKit by TESCHGlobal to Advance Healthcare FHIR Test Data Generation
https://form.io/form-io-teschglobal-partnership/
More news about: Form.io LLC
Feb 16, 2026, 13:38 ET Blood Glucose Monitoring Devices Market to Reach USD 36.8 Billion by 2032, Fueled by CGM Adoption and Home Diagnostics - Credence Research
designed at nearly half the size of earlier Medtronic CGM models.In October 2025, OSR Holdings signed a definitive agreement to acquire Woori IO, a developer of noninvasive glucose monitoring technology, through a share exchange transaction.In April 2025, Cardinal Health completed the
More news about: Credence Research Inc.